Literature DB >> 18932279

Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine.

Adam-J Moeser1, Prashant-K Nighot, Birgit Roerig, Ryuji Ueno, Anthony-T Blikslager.   

Abstract

AIM: To investigate the effects of lubiprostone and Polyethylene Glycol 3350 (PEG) on mucosal barrier repair in ischemic-injured porcine intestine.
METHODS: Ileum from 6 piglets (approximately 15 kg body weight) was subjected to ischemic conditions by occluding the local mesenteric circulation for 45 min in vivo. Ileal tissues from each pig were then harvested and mounted in Ussing chambers and bathed in oxygenated Ringer's solution in vitro. Intestinal barrier function was assessed by measuring transepithelial electrical resistance (TER) and mucosal-to-serosal fluxes of (3)H-mannitol and (14)C-inulin. Statistical analyses of data collected over a 120-min time course included 2-way ANOVA for the effects of time and treatment on indices of barrier function.
RESULTS: Application of 1 micromol/L lubiprostone to the mucosal surface of ischemic-injured ileum in vitro induced significant elevations in TER compared to non-treated tissue. Lubiprostone also reduced mucosal-to-serosal fluxes of (3)H-mannitol and (14)C-inulin. Alternatively, application of a polyethylene laxative (PEG, 20 mmol/L) to the mucosal surface of ischemic tissues significantly increased flux of (3)H-mannitol and (14)C-inulin.
CONCLUSION: This experiment demonstrates that lubiprostone stimulates recovery of barrier function in ischemic intestinal tissues whereas the PEG laxative had deleterious effects on mucosal repair. These results suggest that, unlike osmotic laxatives, lubiprostone stimulates repair of the injured intestinal barrier.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18932279      PMCID: PMC2760184          DOI: 10.3748/wjg.14.6012

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  American Gastroenterological Association Medical Position Statement: guidelines on intestinal ischemia.

Authors: 
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

Review 2.  Gut dysfunction in critically ill patients: a review of the literature.

Authors:  J K Stechmiller; D Treloar; N Allen
Journal:  Am J Crit Care       Date:  1997-05       Impact factor: 2.228

Review 3.  Restoration of barrier function in injured intestinal mucosa.

Authors:  Anthony T Blikslager; Adam J Moeser; Jody L Gookin; Samuel L Jones; Jack Odle
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 4.  Mechanisms of intestinal mucosal repair.

Authors:  A T Blikslager; M C Roberts
Journal:  J Am Vet Med Assoc       Date:  1997-12-01       Impact factor: 1.936

5.  Polyethylene glycol enhances colonic barrier function and ameliorates experimental colitis in rats.

Authors:  Sebastián Videla; Aurelia Lugea; Jaime Vilaseca; Francisco Guarner; Francesc Treserra; Antonio Salas; Ernesto Crespo; Carlos Medina; Juan R Malagelada
Journal:  Int J Colorectal Dis       Date:  2006-10-24       Impact factor: 2.571

6.  Genistein augments prostaglandin-induced recovery of barrier function in ischemia-injured porcine ileum.

Authors:  A T Blikslager; M C Roberts; K M Young; J M Rhoads; R A Argenzio
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-02       Impact factor: 4.052

7.  Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients.

Authors:  C J Doig; L R Sutherland; J D Sandham; G H Fick; M Verhoef; J B Meddings
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

Review 8.  Microcirculatory dysfunction during intestinal ischemia-reperfusion.

Authors:  M Boros
Journal:  Acta Physiol Hung       Date:  2003

9.  ClC-2 chloride secretion mediates prostaglandin-induced recovery of barrier function in ischemia-injured porcine ileum.

Authors:  Adam J Moeser; Melissa M Haskell; Donnie E Shifflett; Dianne Little; Bruce D Schultz; Anthony T Blikslager
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

10.  SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents.

Authors:  John Cuppoletti; Danuta H Malinowska; Kirti P Tewari; Qiu-Ju Li; Ann M Sherry; Myra L Patchen; Ryuji Ueno
Journal:  Am J Physiol Cell Physiol       Date:  2004-06-22       Impact factor: 4.249

View more
  12 in total

Review 1.  [New drugs for the treatment of constipation].

Authors:  Birgit Adam; Tobias Liebregts; Guido Gerken
Journal:  Med Klin (Munich)       Date:  2010-07-30

Review 2.  ClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic target.

Authors:  Younggeon Jin; Anthony T Blikslager
Journal:  Tissue Barriers       Date:  2015-11-13

3.  Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.

Authors:  Eikan Mishima; Shinji Fukuda; Hisato Shima; Akiyoshi Hirayama; Yasutoshi Akiyama; Yoichi Takeuchi; Noriko N Fukuda; Takehiro Suzuki; Chitose Suzuki; Akinori Yuri; Koichi Kikuchi; Yoshihisa Tomioka; Sadayoshi Ito; Tomoyoshi Soga; Takaaki Abe
Journal:  J Am Soc Nephrol       Date:  2014-12-18       Impact factor: 10.121

4.  Oral PEG 15-20 protects the intestine against radiation: role of lipid rafts.

Authors:  Vesta Valuckaite; Olga Zaborina; Jason Long; Martin Hauer-Jensen; Junru Wang; Christopher Holbrook; Alexander Zaborin; Kenneth Drabik; Mukta Katdare; Helena Mauceri; Ralph Weichselbaum; Millicent A Firestone; Ka Yee Lee; Eugene B Chang; Jeffrey Matthews; John C Alverdy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-10-15       Impact factor: 4.052

5.  Lubiprostone: clinical applications beyond constipation.

Authors:  Shailendra Kapoor
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

6.  Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors.

Authors:  John Cuppoletti; Anthony T Blikslager; Jayati Chakrabarti; Prashant K Nighot; Danuta H Malinowska
Journal:  BMC Pharmacol       Date:  2012-05-03

7.  Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells.

Authors:  Galliano Zanello; Mustapha Berri; Joëlle Dupont; Pierre-Yves Sizaret; Romain D'Inca; Henri Salmon; François Meurens
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

8.  Direct interactions between ENaC gamma subunit and ClCN2 in cystic fibrosis epithelial cells.

Authors:  Katherine R Henry; Seakwoo Lee; Douglas Walker; Pamela L Zeitlin
Journal:  Physiol Rep       Date:  2015-01-27

9.  A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa.

Authors:  Sang Bum Kang; Ronald R Marchelletta; Harrison Penrose; Michael J Docherty; Declan F McCole
Journal:  Pharmacol Res Perspect       Date:  2015-03-13

10.  High Molecular Weight Polymer Promotes Bone Health and Prevents Bone Loss Under Salmonella Challenge in Broiler Chickens.

Authors:  Sandi Raehtz; Billy M Hargis; Vivek A Kuttappan; Rifat Pamukcu; Lisa R Bielke; Laura R McCabe
Journal:  Front Physiol       Date:  2018-04-13       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.